<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">82874</article-id><article-id pub-id-type="doi">10.7554/eLife.82874</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group></article-categories><title-group><article-title>An extracellular vesicle targeting ligand that binds to Arc proteins and facilitates Arc transport <italic>in vivo</italic></article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-87025"><name><surname>Lee</surname><given-names>Peter H</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2411-6094</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-87024"><name><surname>Anaya</surname><given-names>Michael</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-10039"><name><surname>Ladinsky</surname><given-names>Mark S</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1036-3513</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-291254"><name><surname>Reitsma</surname><given-names>Justin</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" corresp="yes" id="author-17933"><name><surname>Zinn</surname><given-names>Kai</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-6706-5605</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Division of Biology and Biological Engineering</institution>, <institution>California Institute of Technology</institution>, <addr-line><named-content content-type="city">Pasadena</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution>AbbVie</institution>, <addr-line><named-content content-type="city">North Chicago</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1027"><name><surname>VijayRaghavan</surname><given-names>K</given-names></name><role>Reviewing editor</role><aff><institution>National Centre for Biological Sciences, Tata Institute of Fundamental Research</institution>, <country>India</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>hlee@caltech.edu</email> (PL);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>zinnk@caltech.edu</email> (KZ);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>16</day><month>06</month><year>2023</year></pub-date><volume>12</volume><elocation-id>e82874</elocation-id><history><date date-type="received"><day>21</day><month>08</month><year>2022</year></date><date date-type="accepted"><day>15</day><month>06</month><year>2023</year></date></history><permissions><copyright-statement>Â© 2023, Lee et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Lee et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-82874-v1.pdf"/><abstract><p>Communication between distant cells can be mediated by extracellular vesicles (EVs) that deliver proteins and RNAs to recipient cells. Little is known about how EVs are targeted to specific cell types. Here we identify the <italic>Drosophila</italic> cell-surface protein Stranded at second (Sas) as a targeting ligand for EVs. Full-length Sas is present in EV preparations from transfected <italic>Drosophila</italic> Schneider 2 (S2) cells. Sas is a binding partner for the Ptp10D receptor tyrosine phosphatase, and Sas-bearing EVs preferentially target to cells expressing Ptp10D. We used co-immunoprecipitation and peptide binding to show that the cytoplasmic domain (ICD) of Sas binds to dArc1 and mammalian Arc. dArc1 and Arc are related to retrotransposon Gag proteins. They form virus-like capsids which encapsulate <italic>Arc</italic> and other mRNAs and are transported between cells via EVs. The Sas ICD contains a motif required for dArc1 binding that is shared by the mammalian and <italic>Drosophila</italic> amyloid precursor protein (APP) orthologs, and the APP ICD also binds to mammalian Arc. Sas facilitates delivery of dArc1 capsids bearing <italic>dArc1</italic> mRNA into distant Ptp10D-expressing recipient cells <italic>in vivo</italic>.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd><italic>D. melanogaster</italic></kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution>NINDS</institution></institution-wrap></funding-source><award-id>NS28182</award-id><principal-award-recipient><name><surname>Zinn</surname><given-names>Kai</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution>NINDS</institution></institution-wrap></funding-source><award-id>NS096509</award-id><principal-award-recipient><name><surname>Zinn</surname><given-names>Kai</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Justin Reitsma, is affiliated with AbbVie. The author has no other competing interests to declare.</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>Key data generated or analysed during this study are included in the manuscript and supporting files.</p></sec><supplementary-material><ext-link xlink:href="elife-82874-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>